UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	September 14, 2022

Accession Number:	0001818382-22-000137
Submission Type:	POS AM
CIK: 0001818382 Company Name: Humacyte, Inc. File Number: 333-259624